41,634 Procter & Gamble Company (The) $PG Shares Sold by Inscription Capital LLC

Inscription Capital LLC reduced its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 65.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,961 shares of the company’s stock after selling 41,634 shares during the period. Inscription Capital LLC’s holdings in Procter & Gamble were worth $3,190,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Procter & Gamble in the second quarter worth $27,862,105,000. State Street Corp grew its position in Procter & Gamble by 1.0% during the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after buying an additional 965,461 shares in the last quarter. Bank of America Corp DE purchased a new position in Procter & Gamble during the second quarter worth about $3,850,628,000. Bank of New York Mellon Corp bought a new position in Procter & Gamble in the 2nd quarter worth about $2,281,505,000. Finally, Dimensional Fund Advisors LP increased its stake in Procter & Gamble by 2.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after acquiring an additional 300,280 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 0.1%

Shares of PG stock opened at $167.15 on Friday. The business has a 50-day moving average price of $151.56 and a two-hundred day moving average price of $149.34. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $170.52. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. The firm has a market cap of $387.41 billion, a P/E ratio of 25.17, a price-to-earnings-growth ratio of 4.11 and a beta of 0.36.

Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. The firm had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company’s revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.99 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.6%. Procter & Gamble’s dividend payout ratio is currently 65.51%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a research report on Tuesday, October 6th. Bank of America cut their price objective on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a report on Friday, July 10th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $161.00 target price on shares of Procter & Gamble in a research note on Thursday, October 22nd. HSBC downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their target price for the company from $182.00 to $149.00 in a research note on Thursday, July 30th. Finally, Citigroup lifted their target price on shares of Procter & Gamble from $180.00 to $187.00 and gave the company a “buy” rating in a research report on Friday, October 23rd. Fifteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $170.57.

View Our Latest Stock Analysis on Procter & Gamble

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: P&G recently reached a 52-week high as investors favored reliable dividend-paying consumer-staples companies amid political uncertainty. Its latest reported quarter also beat earnings and revenue estimates, with sales up 4% year over year. Article: Dividend stocks reach highs
  • Neutral Sentiment: P&G will webcast its November 19 Investor Day, where its leadership team plans to discuss strategy and the company’s long-term transformation. Investors may look for details on growth plans and execution. Article: Investor Day webcast
  • Neutral Sentiment: Bernstein maintained a Hold rating on PG, suggesting a cautious view rather than a clear near-term catalyst. Article: Bernstein rating
  • Negative Sentiment: CFO Andre Schulten sold 33,624 shares, reducing his direct holding by about 34%. Insider sales can weigh on sentiment, although they do not necessarily signal a change in the company’s outlook. Article: CFO share sale
  • Negative Sentiment: A comparison of P&G and Colgate-Palmolive flagged rising oil prices and cautious U.S. shoppers as challenges for margins. The report says the companies’ margins are moving in opposite directions but does not specify which direction applies to P&G. Article: P&G and Colgate-Palmolive comparison

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Sundar Raman sold 38,253 shares of Procter & Gamble stock in a transaction that occurred on Friday, October 30th. The shares were sold at an average price of $165.00, for a total transaction of $6,311,745.00. Following the transaction, the chief executive officer directly owned 47,745 shares of the company’s stock, valued at approximately $7,877,925. This trade represents a 44.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Shailesh Jejurikar sold 35,000 shares of Procter & Gamble stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the transaction, the chief executive officer directly owned 55,391 shares in the company, valued at $9,033,718.19. This trade represents a 38.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 161,709 shares of company stock valued at $26,244,058. 0.23% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.